Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mylan Names Anthony Mauro CCO

This article was originally published in Scrip

Executive Summary

Mylan N.V has appointed Anthony Mauro chief commercial officer; he has previously held various positions in the company including president of Mylan Pharmaceuticals Inc., chief operating officer of Mylan Pharmaceuticals ULC., in Canada, vice president of North America strategic development; and vice president of North America sales. He previously was chair of the board for US Generic Pharmaceutical Association (GPhA) for two consecutive terms in 2012 and 2013 and prior to this, he was vice chair of the board for two consecutive terms.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC064604

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel